ResearcherNankai UniversityActive in the last 2 years
Jie Hao
Matched on ORCID iD 0000-0002-0273-8047; OpenAlex author ID A5108059994. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2023: 1 paper · 2024: 2 papers · 2025: 3 papers
Papers 6
- Endoscopic ultrasound elastography in solid pancreatic lesions: individual and combined performance of strain ratio, fat-lesion strain ratio, and mean strain h… Co-author DOI 10.1007/s10238-025-01969-5↗
- Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9. Co-author DOI 10.1186/s13062-025-00595-1↗
- Tobacco carcinogen NNK promotes pancreatic cancer proliferation via LINC00857/β-catenin. Co-author DOI 10.18332/tid/203455↗
- EPYC functions as a novel prognostic biomarker for pancreatic cancer. Co-author DOI 10.1038/s41598-024-51478-w↗
- Erianin inhibits the progression of pancreatic cancer by directly targeting AKT and ASK1. Co-author DOI 10.1186/s12935-024-03533-9↗
- An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer. Co-author DOI 10.3389/fgene.2023.1084275↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cancan Zhou · 4 shared papers, 2023–2025 · strength 0.88
- Paper Tobacco carcinogen NNK promotes pancreatic cancer proliferation via LINC00857/β-catenin. DOI 10.18332/tid/203455↗
- Paper Endoscopic ultrasound elastography in solid pancreatic lesions: individual and combined performance of strain ratio, fa… DOI 10.1007/s10238-025-01969-5↗
- Paper Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9. DOI 10.1186/s13062-025-00595-1↗
- Weikun Qian · 3 shared papers, 2025 · strength 0.67
- Paper Tobacco carcinogen NNK promotes pancreatic cancer proliferation via LINC00857/β-catenin. DOI 10.18332/tid/203455↗
- Paper Endoscopic ultrasound elastography in solid pancreatic lesions: individual and combined performance of strain ratio, fa… DOI 10.1007/s10238-025-01969-5↗
- Paper Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9. DOI 10.1186/s13062-025-00595-1↗
- Zheng Wang · 2 shared papers, 2025 · strength 0.45
- Qingyong Ma · 2 shared papers, 2025 · strength 0.45
- Ruiqi Cao · 2 shared papers, 2025 · strength 0.45
- Shuai Wu · 2 shared papers, 2025 · strength 0.44
- Zhen Yang · 2 shared papers, 2024 · strength 0.44
- Ming Gao · 1 shared paper, 2024 · strength 0.24
- Jiantao Mo · 1 shared paper, 2025 · strength 0.23
- Hao Sun · 1 shared paper, 2025 · strength 0.22
- Fangzhou Wang · 1 shared paper, 2025 · strength 0.22
- Zheng Wu · 1 shared paper, 2025 · strength 0.22
- Zeen Zhu · 1 shared paper, 2025 · strength 0.22
- Wunai Zhang · 1 shared paper, 2025 · strength 0.22
- Zheng Wu · 1 shared paper, 2025 · strength 0.22
- Xuqi Li · 1 shared paper, 2025 · strength 0.22
- Rongqian Wu · 1 shared paper, 2023 · strength 0.20
- Zhenhua Ma · 1 shared paper, 2023 · strength 0.20
- Huaqing Wang · 1 shared paper, 2024 · strength 0.20
- Ruxue Liu · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.